Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.
2.

CD138 (syndecan-1), a plasma cell marker immunohistochemical profile in hematopoietic and nonhematopoietic neoplasms.

O'Connell FP, Pinkus JL, Pinkus GS.

Am J Clin Pathol. 2004 Feb;121(2):254-63.

PMID:
14983940
3.

Expression of the plasmacytoid dendritic cell marker BDCA-2 supports a spectrum of maturation among CD4+ CD56+ hematodermic neoplasms.

Jaye DL, Geigerman CM, Herling M, Eastburn K, Waller EK, Jones D.

Mod Pathol. 2006 Dec;19(12):1555-62. Epub 2006 Sep 22.

4.

Rare expression of T-cell markers in classical Hodgkin's lymphoma.

Tzankov A, Bourgau C, Kaiser A, Zimpfer A, Maurer R, Pileri SA, Went P, Dirnhofer S.

Mod Pathol. 2005 Dec;18(12):1542-9.

5.

Usefulness of flow cytometry for differential diagnosis of precursor and peripheral T-cell and NK-cell lymphomas: analysis of 490 cases.

Karube K, Aoki R, Nomura Y, Yamamoto K, Shimizu K, Yoshida S, Komatani H, Sugita Y, Ohshima K.

Pathol Int. 2008 Feb;58(2):89-97. doi: 10.1111/j.1440-1827.2007.02195.x.

PMID:
18199158
6.
7.
8.

Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.

Wilkerson MJ, Dolce K, Koopman T, Shuman W, Chun R, Garrett L, Barber L, Avery A.

Vet Immunol Immunopathol. 2005 Jul 15;106(3-4):179-96.

PMID:
15963817
9.

Intestinal T-cell and natural killer-cell lymphomas in Taiwan with special emphasis on 2 distinct cellular types: natural killer-like cytotoxic T cell and true natural killer cell.

Tung CL, Hsieh PP, Chang JH, Chen RS, Chen YJ, Wang JS.

Hum Pathol. 2008 Jul;39(7):1018-25. doi: 10.1016/j.humpath.2007.11.003. Epub 2008 May 14.

PMID:
18482744
10.

Non-B, non-T neoplasms with lymphoblast morphology: further clarification and classification.

Karube K, Ohshima K, Tsuchiya T, Yamaguchi T, Suefuji H, Suzumiya J, Harada M, Kikuchi M.

Am J Surg Pathol. 2003 Oct;27(10):1366-74.

PMID:
14508398
11.

Aberrant expression of T-cell markers in acute myeloid leukemia.

Lewis RE, Cruse JM, Sanders CM, Webb RN, Suggs JL.

Exp Mol Pathol. 2007 Dec;83(3):462-3. Epub 2007 Sep 7.

PMID:
17927977
12.
13.

CD4+CXCR4highCD69+ T cells accumulate in lung adenocarcinoma.

Wald O, Izhar U, Amir G, Avniel S, Bar-Shavit Y, Wald H, Weiss ID, Galun E, Peled A.

J Immunol. 2006 Nov 15;177(10):6983-90.

14.

CD4(+) CD56(+) lineage-negative malignancies are rare tumors of plasmacytoid dendritic cells.

Reichard KK, Burks EJ, Foucar MK, Wilson CS, Viswanatha DS, Hozier JC, Larson RS.

Am J Surg Pathol. 2005 Oct;29(10):1274-83.

PMID:
16160468
15.

Cytologic features of NK/T-cell lymphoma.

Chan AB, Chan WY, Chow JH.

Acta Cytol. 2003 Jul-Aug;47(4):595-601.

PMID:
12920752
16.

CD8+, CD56+ (natural killer-like) T-cell lymphoma involving the small intestine with no evidence of enteropathy: clinicopathology and molecular study of five Japanese patients.

Akiyama T, Okino T, Konishi H, Wani Y, Notohara K, Tsukayama C, Tsunoda T, Tasaka T, Masaki Y, Sugihara T, Sadahira Y.

Pathol Int. 2008 Oct;58(10):626-34. doi: 10.1111/j.1440-1827.2008.02281.x.

PMID:
18801082
17.

Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review.

Petrella T, Bagot M, Willemze R, Beylot-Barry M, Vergier B, Delaunay M, Meijer CJ, Courville P, Joly P, Grange F, De Muret A, Machet L, Dompmartin A, Bosq J, Durlach A, Bernard P, Dalac S, Dechelotte P, D'Incan M, Wechsler J, Teitell MA.

Am J Clin Pathol. 2005 May;123(5):662-75. Review.

PMID:
15981806
18.

Nasal-type extranodal natural killer/T-cell lymphomas: a clinicopathologic and genotypic study of 42 cases in Singapore.

Ng SB, Lai KW, Murugaya S, Lee KM, Loong SL, Fook-Chong S, Tao M, Sng I.

Mod Pathol. 2004 Sep;17(9):1097-107.

19.

TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis.

Petrella T, Meijer CJ, Dalac S, Willemze R, MaynadiƩ M, Machet L, Casasnovas O, Vergier B, Teitell MA.

Am J Clin Pathol. 2004 Aug;122(2):307-13.

PMID:
15323148
20.

Defective infiltration of natural killer cells in MICA/B-positive renal cell carcinoma involves beta(2)-integrin-mediated interaction.

Sconocchia G, Spagnoli GC, Del Principe D, Ferrone S, Anselmi M, Wongsena W, Cervelli V, Schultz-Thater E, Wyler S, Carafa V, Moch H, Terracciano L, Tornillo L.

Neoplasia. 2009 Jul;11(7):662-71.

Supplemental Content

Support Center